Medtronic PLC (NYSE: MDT) has reported earnings for its third fiscal quarter (ending January 31) of $1.01 versus $0.99 for the same period a year ago — an increase of 2%. For the latest four quarters through January 31, E.P.S. were $3.29 compared to $3.16 a year ago — an increase of 4%.
Recent Price Action
Medtronic PLC (NYSE: MDT) stock closed at $86.07 on 2/18/25 after a large decline of -7.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 208% of normal. The stock has declined -4.4% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Medtronic has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Medtronic has a neutral Appreciation Score of 41 and a neutral Power Rating of 57, with the Low Neutral Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment